Key facts
- Naluri’s last known valuation is $25.3M (Jun 2021).
- It has raised $22.6M; the latest was Later Stage VC ($5.0M) in Aug 2025.
- Notable investors include MedTech Innovator, Global Founders Capital, StartX (US), KB Investment, Palm Drive Capital — 26 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 26 names
- ·Watchlist + deal alerts for Naluri
- ·The full record, as it builds
Funding rounds
No funding rounds for Naluri are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Naluri
Developer of a digital therapeutics platform designed to connect employees or policyholders with health psychologists. The company's platform combines behavioral science, data science and digital design, as well as offering coaching to lose weight and helping organizations predict, prevent and manage the leading cardiometabolic and mental health conditions, enabling users to achieve and sustain health outcomes such as better stress management and reduction in blood pressure or blood sugar levels.
- Sector
- Healthcare
- HQ
- Singapore, Singapore
- Founded
- 2017
- Employees
- 270
- Website
- naluri.life/
- Ownership
- Privately Held (backing)
Naluri doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Naluri shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Naluri in its N-PORT filings yet. We sweep new filings monthly.